Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4. - Wikidata - awgldk - TriplyDB

Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4.

Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4.

http://www.wikidata.org/entity/Q37211408

about

Metastable pluripotent states in NOD-mouse-derived ESCs Rationale and Methodology of Reprogramming for Generation of Induced Pluripotent Stem Cells and Induced Neural Progenitor Cells Chemically Induced Reprogramming of Somatic Cells to Pluripotent Stem Cells and Neural Cells Pluripotent Stem Cells: Current Understanding and Future Directions G-protein Coupled Receptor Signaling in Pluripotent Stem Cell-derived Cardiovascular Cells: Implications for Disease Modeling Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and Challenges Mesenchymal and induced pluripotent stem cells: general insights and clinical perspectives Concise review: A chemical approach to control cell fate and function iPSCs and small molecules: a reciprocal effort towards better approaches for drug discovery The roles of the reprogramming factors Oct4, Sox2 and Klf4 in resetting the somatic cell epigenome during induced pluripotent stem cell generation Overcoming barriers to the clinical utilization of iPSCs: reprogramming efficiency, safety and quality Genetic background affects induced pluripotent stem cell generation Molecular basis for the high-affinity binding and stabilization of firefly luciferase by PTC124 Firefly Luciferase in Chemical Biology: A Compendium of Inhibitors, Mechanistic Evaluation of Chemotypes, and Suggested Use As a Reporter Induced pluripotent stem cells as a model for accelerated patient- and disease-specific drug discovery.Urine-derived induced pluripotent stem cells as a modeling tool to study rare human diseases Reprogramming of germ cells into pluripotency Utilizing induced pluripotent stem cells (iPSCs) to understand the actions of estrogens in human neurons Reprogramming with Small Molecules instead of Exogenous Transcription Factors Profile of the GSK published protein kinase inhibitor set across ATP-dependent and-independent luciferases: implications for reporter-gene assays High-throughput screening reveals alsterpaullone, 2-cyanoethyl as a potent p27Kip1 transcriptional inhibitor Signalling Through Retinoic Acid Receptors is Required for Reprogramming of Both Mouse Embryonic Fibroblast Cells and Epiblast Stem Cells to Induced Pluripotent Stem Cells Small RNA-mediated regulation of iPS cell generation.Efficient generation of nonhuman primate induced pluripotent stem cells.A kinase inhibitor screen identifies small-molecule enhancers of reprogramming and iPS cell generation.Cancer stem cells in solid tumors: elusive or illusive?Two factor reprogramming of human neural stem cells into pluripotency Progress toward the clinical application of patient-specific pluripotent stem cells Controlling destiny through chemistry: small-molecule regulators of cell fate.Reprogramming cell fates by small molecules.Future alternative therapies for β-thalassemia.NANOG reporter cell lines generated by gene targeting in human embryonic stem cells.iPS cells reprogrammed from human mesenchymal-like stem/progenitor cells of dental tissue origin Small molecules, big roles -- the chemical manipulation of stem cell fate and somatic cell reprogramming.Kinome-wide functional analysis highlights the role of cytoskeletal remodeling in somatic cell reprogramming.Spinal muscular atrophy: mechanisms and therapeutic strategies.Dedifferentiation of human primary thyrocytes into multilineage progenitor cells without gene introduction Reprogramming ovarian and breast cancer cells into non-cancerous cells by low-dose metformin or SN-38 through FOXO3 activation Mechanisms for enhancing cellular reprogramming Molecular control of induced pluripotency.

P2860

Q24645721-00B6F594-9699-4CB7-923B-12760D1BA499 Q26750951-F03ED982-8BA3-47D1-BCD9-2C317F45AE90 Q26767244-C8E592C8-DA6D-428E-9224-901D7BEEF53F Q26769981-BC558617-43F5-4CD4-8EA7-F0B33C65D723 Q26772221-21DFFBEA-5CA5-4DD5-AC01-350C1A556C6B Q26775061-D161B8E2-C75C-4449-B957-3EB544EAAB9E Q26785623-02B6BAD2-671E-499B-8305-383D2D094E02 Q26863607-E7AD0F95-66C0-41C6-9B7B-C156E6AD2EF3 Q26865055-AFFDA545-3626-4F12-BB1F-FDD42DCCE9A2 Q26999027-800E6D4C-2B5D-444F-85D3-CBE2FE400965 Q27014026-03981474-CC20-49E3-BADB-58AFF60D17E9 Q27499837-4E27E596-4863-453B-905C-540519E3A330 Q27660081-659CAEFA-7C08-4695-902E-87A47A4BF792 Q27671683-0BA2160C-1FE8-4E32-B1BC-C57BA51E9676 Q27693217-1C123F71-4844-4AB7-ADD1-7D6947544891 Q28073204-F033524D-199F-4F38-8CEC-F33BADE0A1A3 Q28078353-FF429741-5EAD-4A3B-B070-D90D2047C6A1 Q28081565-71D83D4D-7D73-4A96-AF54-7D0E3EDE796E Q28084394-A47E260D-1BCD-49B7-86A4-828BDD12FA56 Q28487785-6C928A9E-AFAD-4EE1-869A-21F6A395F9F3 Q28541113-BDA48A26-2DB3-48B7-9F03-F744C4F67398 Q28834460-45B9BFD1-2DC6-485E-B679-58B892DE9946 Q30498334-EEC9818D-B32A-43FF-9A8E-3C334FF86400 Q30502017-2BB3A5CE-12DC-4C8A-8955-7AD97D0966DA Q30539955-6B266BB8-049C-4BFC-90C8-C965BB9C8C3B Q33349066-F759920E-618C-4A06-BD4F-CBDDDF61B32E Q33504579-F9588861-C478-44BD-8644-17856812CDD3 Q33559694-F83A83DE-186C-441A-A5F2-230BE59BFB32 Q33593482-39913464-AE9E-463C-B7F4-495D8B2C7788 Q33628088-CF3D6F27-D7E0-4B0F-8A0A-BD4DC16B51AB Q33659678-91665202-2F51-4DD8-9F94-595D419B740A Q33686972-3FAB03A6-67D6-4CAE-BEF8-79D26998DB8A Q33778074-26F5E2CA-CB11-473A-98B5-3E22096FD120 Q33793268-B7BE721C-CA37-48E1-9D19-131CEABE7438 Q33807533-355BC782-01B8-4146-8C85-FB967DD4D269 Q33871311-67F4896D-832D-45B7-A35F-E4D0B01BFAC7 Q33893951-D1F9D516-29F5-4549-8447-A7BBB648EC78 Q33942068-85A980E5-6EC3-4948-8A22-2FF4512E277D Q33943321-DD94F161-EC54-4F29-89ED-28C517F7B05C Q33957979-9332BAD9-19BA-4125-9695-E0838BDFE386

P2860

Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4.

http://www.wikidata.org/entity/Q37211408

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Reprogramming of murine fibrob ...... mical complementation of Klf4.

@en

Reprogramming of murine fibrob ...... mical complementation of Klf4.

@nl

type

label

Reprogramming of murine fibrob ...... mical complementation of Klf4.

@en

Reprogramming of murine fibrob ...... mical complementation of Klf4.

@nl

prefLabel

Reprogramming of murine fibrob ...... mical complementation of Klf4.

@en

Reprogramming of murine fibrob ...... mical complementation of Klf4.

@nl

P1433

Q37211408-59A5EC8C-79FE-4B00-8A5C-2B3A75E40ED5

P1476

Q37211408-9A872168-386B-4C24-9A97-0A275C0A5786

P2093

Q37211408-16A53226-D8C7-47BF-A3D4-BC15D56DA984

Q37211408-3C42CC66-CE31-451F-B05C-487846F4BC51

Q37211408-418C2A7B-45AF-4727-B87D-3CD0D6AED18F

Q37211408-431ED5E4-88E7-4522-BE98-FA8559E3695C

Q37211408-460635D6-0224-4692-8120-FCA6FB0B8218

Q37211408-4FCAD2CE-5413-4679-AFE3-8DDB56C84798

Q37211408-564CD7CE-285D-4052-9290-E9C5569BB4A5

Q37211408-58BFE060-E499-4388-A519-1C83E0DCA7E2

Q37211408-7066038D-4CDB-4275-80A9-B2D22D7F6BA5

Q37211408-79C821F2-5A26-408B-925F-A8B82D123CE5

P2860

Q37211408-02E35DBC-CA2D-4EED-BF16-DBF63D60A02F

Q37211408-05D173F9-0AD0-4F65-AC1A-9CEEA1389576

Q37211408-0E5FCD04-7EAC-45B8-9FDE-D811C507A5F6

Q37211408-107E45E9-101B-413D-97AB-5AEF19B0461E

Q37211408-21804A05-C941-461F-8483-F90F5D6685F4

Q37211408-25416064-3D13-4F87-9058-5B2871903F79

Q37211408-38F8B61D-E6CC-4FE9-A0DF-57E327003403

Q37211408-3F6B1FD7-616A-4BED-AF81-2CC88667FA60

Q37211408-4D3FB9FD-59F5-4BDF-BCC3-D4B9900B8D59

Q37211408-4DBBD46D-C1DF-4C0B-B824-BDBDB1E3BAB6

P304

Q37211408-CFBD44E9-A824-4F4A-A8BB-1F111748789D

P31

Q37211408-0F3EB4FC-6E8D-45C8-BA41-210545B3CC53

P356

Q37211408-F61084D8-69FA-4A9D-AFD2-51D9157F6141

P407

Q37211408-6D53435C-9778-4E02-A34B-1EEC3105599F

P433

Q37211408-2CE6C7E3-8FFB-4DC6-8CDB-67C78DFFC384

P478

Q37211408-BCEB961B-8967-4950-A3BE-1AEDDC142449

P50

Q37211408-2C95045E-AE15-4374-B560-A0692A2D0909

Q37211408-6A4C25FC-CAB8-40C8-961E-53F8275E7EB5

Q37211408-AA387E4D-7527-4019-A8ED-A50D13FDC2CF

Q37211408-AA9E0773-5DE6-4E1B-B920-993141A17C03

Q37211408-E8A40E49-C2C1-433E-8D7E-712D6A36559D

P577

Q37211408-0737DF9D-D4A0-40A3-927B-EC4730329637

P5875

Q37211408-8C077C79-355C-4F1B-BC25-FAA3C62C91B4

P698

Q37211408-A6E2CAB4-1FF0-430A-950D-914524073B50

P932

Q37211408-23BD31C6-B30F-4216-AFDA-49AAA5710EBB

P356

PNAS.0903860106

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Reprogramming of murine fibrob ...... mical complementation of Klf4.

@en

P2093

Achim Brinker

http://www.w3.org/2001/XMLSchema#string

Bradley D Charette

http://www.w3.org/2001/XMLSchema#string

Charles Y Cho

http://www.w3.org/2001/XMLSchema#string

Conrad Kunick

http://www.w3.org/2001/XMLSchema#string

Costas A Lyssiotis

http://www.w3.org/2001/XMLSchema#string

Divya Mathur

http://www.w3.org/2001/XMLSchema#string

Judith Staerk

http://www.w3.org/2001/XMLSchema#string

Laure C Bouchez

http://www.w3.org/2001/XMLSchema#string

Michael Bollong

http://www.w3.org/2001/XMLSchema#string

Michael Garcia

http://www.w3.org/2001/XMLSchema#string

P2860

Virus-free induction of pluripotency and subsequent excision of reprogramming factors

Oct4 expression is not required for mouse somatic stem cell self-renewal

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

Generation of germline-competent induced pluripotent stem cells

The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells

Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells

An extended transcriptional network for pluripotency of embryonic stem cells

Discovery and initial characterization of the paullones, a novel class of small-molecule inhibitors of cyclin-dependent kinases

Promotion of reprogramming to ground state pluripotency by signal inhibition

Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors

P304

8912-8917

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0903860106

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P50

Styliani Markoulaki

Luke L. Lairson

Rudolf Jaenisch

P577

2009-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24432840

http://www.w3.org/2001/XMLSchema#string

P698

19447925

http://www.w3.org/2001/XMLSchema#string

P932

2690053

http://www.w3.org/2001/XMLSchema#string